Hepaglide 2.4 mg Multi-dose Disposable Pen Solution for Injection 3 ml
$323.00 – $1,352.00Price range: $323.00 through $1,352.00
| Pack Size | Price | Unit Price | Quantity | |
|---|---|---|---|---|
| 1 Box | $323.00 | $323.00 / box | ||
| 2 Box | $631.70 | $315.85 / box Save 2% | ||
| 3 Box | $906.10 | $302.03 / box Save 6% | ||
| 4 Box | $1,146.20 | $286.55 / box Save 11% | ||
| 5 Box | $1,352.00 | $270.40 / box Save 16% |
Product Introduction: Hepaglide (Semaglutide) 2.4mg Injection
Hepaglide 2.4mg Injection (Semaglutide) represents the final and most powerful stage in the semaglutide titration pathway. This maximum-strength pen, manufactured by Alkem Laboratories Ltd, is specifically designed for patients who require the highest level of appetite suppression. Specifically, it provides the hormonal saturation necessary to achieve significant, long-term weight reduction for those who have successfully transitioned through the lower doses.
As a premium generic equivalent to Wegovy 2.4mg, Hepaglide delivers identical pharmaceutical efficacy at a significantly more accessible price point. Furthermore, clinical experts recognize this 2.4mg dose as the “therapeutic ceiling,” which is where patients typically experience the most dramatic improvements in body composition. By utilizing Alkem’s precision-engineered multi-dose delivery system, patients in the USA, UK, and Australia can maintain their peak results with pharmaceutical-grade consistency.
What is Hepaglide (Semaglutide) 2.4mg Injection?
Hepaglide (Semaglutide) 2.4mg Injection is a high-potency, once-weekly GLP-1 receptor agonist produced by Alkem Laboratories Ltd. This specific concentration represents the maximum approved dosage for chronic weight management. Specifically, it serves as the Indian generic equivalent to Wegovy 2.4mg, which is the global gold standard for treating obesity and metabolic health.
The Peak of Semaglutide Therapy
While lower doses are used to prime the body, the 2.4mg strength is considered the therapeutic maintenance goal. Furthermore, clinical data from the STEP trials has demonstrated that Hepaglide 2.4mg can lead to an average body weight reduction of 15% to 17% when combined with lifestyle changes. By doubling the hormonal signal found in many standard diabetes doses, Hepaglide 2.4mg provides the saturation needed to suppress appetite at a central nervous system level.
Alkem?s WHO-GMP Manufacturing Excellence
Every Hepaglide 2.4mg pen is produced in state-of-the-art facilities that meet international safety standards. Consequently, patients in the USA, UK, and Australia receive a product that matches the purity and safety profile of brand-name biologics. Each comprehensive 4-week kit includes:
One Pre-filled Multi-dose Pen: Calibrated to deliver exactly four 2.4mg doses.
Included Sterile Needles: Four pieces are provided to ensure a fresh, painless application each week.
Cleaning Accessories: Four alcohol swabs are included for professional-grade site sterilization.
As a result of Alkem?s commitment to quality, Hepaglide offers a reliable and cost-effective pathway to long-term weight maintenance and improved cardiovascular health.
Technical Analysis: Hepaglide 2.4mg Multi-dose Injection
The Hepaglide 2.4mg pen functions by mimicking the natural GLP-1 hormone to regulate metabolic signals. By reducing hunger triggers and slowing the digestion process, this high-dose medication helps patients control their calorie intake more effectively. Specifically, this 2.4mg strength is the final maintenance goal in the titration pathway.
| Specification | Value |
| Active Ingredient | Semaglutide |
| Concentration | 3.2 mg/mL |
| Total Pen Volume | 3 mL |
| Total Content | 9.6 mg per pen (Four 2.4mg doses) |
| Pen Type | Multi-dose Disposable |
| Included Accessories | 4 Needles & 4 Alcohol Swabs |
| Manufacturer | Alkem Laboratories Ltd |
Comprehensive Administration Kit
To support a full month of maximum-strength therapy, every box is sold as a complete kit. Furthermore, these supplies ensure a sterile and convenient experience for the user. Each package contains:
One Multi-dose Disposable Pen: Pre-filled with 9.6mg of Semaglutide for four weekly applications.
Sterile Needle Supply: Four fresh needles are included to maintain hygiene for every dose.
Sanitization Tools: Four alcohol swabs are provided for professional-grade site preparation.
Uses of Hepaglide (Semaglutide) 2.4mg Injection
The 2.4mg dose of Hepaglide serves as the designated therapeutic ceiling for semaglutide therapy. Specifically, doctors prescribe this long-term maintenance strength for adults who have successfully titrated through the lower initiation and escalation phases. Manufactured by Alkem Laboratories Ltd, this maximum-strength injection is utilized to address complex metabolic challenges that require a high-intensity hormonal signal.
1. Chronic Weight Management and Obesity
For many patients, this 2.4mg concentration acts as the primary tool to achieve and sustain significant weight reduction. Specifically, it is indicated for:
Obese Adult Populations: Individuals with a Body Mass Index (BMI) of 30 kg/m² or greater.
Overweight Management with Comorbidities: Patients with a BMI of 27 kg/m² or greater who also suffer from weight-related conditions like hypertension or type 2 diabetes.
Maintenance of Progress: Consequently, it helps prevent weight regain once initial fat loss goals have been reached.
2. Reduction of Cardiovascular Risk
Beyond weight loss, clinical evidence suggests that this specific dose provides vital heart protection. Furthermore, Hepaglide 2.4mg is used to:
Lower Major Cardiac Events: It helps reduce the risk of non-fatal heart attack, stroke, or cardiovascular death.
Improve Vascular Health: As a result, the injection decreases systemic inflammation in overweight adults with established heart disease.
3. Advanced Metabolic Regulation
Because Alkem Laboratories Ltd produces this to strict pharmaceutical standards, it is highly effective at:
Enhancing Insulin Sensitivity: It improves the body’s natural response to insulin, which is often impaired by chronic obesity.
Establishing Satiety: Hepaglide 2.4mg provides the strongest signal to the brain’s hunger centers, marking the final step in the semaglutide titration pathway.
How Hepaglide (Semaglutide) 2.4mg Injection Works
Hepaglide (Semaglutide) 2.4mg Injection functions as a potent GLP-1 receptor agonist that targets the biological roots of hunger and insulin resistance. Manufactured by Alkem Laboratories Ltd, this 2.4mg dose provides the highest approved concentration of the active ingredient to ensure maximum metabolic impact. Specifically, Hepaglide 2.4mg mimics the naturally occurring Glucagon-Like Peptide-1 hormone to communicate directly with several organ systems.
1. Central Nervous System Regulation
The primary mechanism involves the brain’s hunger centers located in the hypothalamus. Furthermore, Hepaglide binds to these receptors to effectively “switch off” persistent food cravings and the psychological urge to eat. Consequently, patients report a dramatic reduction in “food noise,” making it significantly easier to maintain the calorie deficit required for substantial weight loss.
2. Gastric Emptying and Satiety
Within the digestive system, the 2.4mg dose slows down the speed at which your stomach empties its contents. As a result, the sensation of physical fullness lasts much longer after consuming even a small meal. This mechanical delay ensures that you feel satisfied throughout the day, preventing overeating.
3. Advanced Glucose Management
Although this strength is the maintenance dose for weight loss, it also provides superior glycemic support. Specifically, it signals the pancreas to release insulin only when blood sugar levels are elevated. Therefore, it provides a glucose-dependent response that stabilizes blood sugar without a high risk of hypoglycemia.
Benefits of Hepaglide (Semaglutide) 2.4mg Injection
The 2.4mg dose of Hepaglide is the most powerful clinically validated strength in the semaglutide class. Specifically, it is engineered to provide the maximum level of hormonal saturation needed for long-term chronic weight management. Manufactured by Alkem Laboratories Ltd, this premium injection offers world-class efficacy for patients who have completed their titration journey.
Peak Weight Loss Results: Clinical data shows average weight loss of around 15% of total body weight.
Maximum Appetite Control: Strong suppression of hunger and cravings.
Significant Cardiovascular Protection: Reduced risk of heart-related complications.
Improved Metabolic Health: Better insulin sensitivity and inflammation reduction.
Cost Efficiency: Access to high-quality treatment at a lower cost.
Dosage Escalation Pathway of Hepaglide (Semaglutide) 2.4mg Injection
The path to the 2.4mg maintenance dose is a structured 17-week journey. Specifically, patients must follow a gradual titration schedule to allow the body to acclimate to the GLP-1 hormone levels. This slow escalation is essential for minimizing gastrointestinal side effects and ensuring long-term success.
Initiation Phase (Weeks 1–4): 0.25mg once weekly.
First Escalation (Weeks 5–8): 0.5mg once weekly.
Second Escalation (Weeks 9–12): 1.0mg once weekly.
Final Step-Up (Weeks 13–16): 1.7mg once weekly.
Maintenance Level (Week 17+): 2.4mg once weekly.
Furthermore, you must never skip these titration steps or start therapy directly at the 2.4mg dose. Consequently, jumping straight to the maximum strength can lead to severe nausea and vomiting.
Side Effects of Hepaglide (Semaglutide) 2.4mg Injection
While Hepaglide (Semaglutide) 2.4mg Injection provides significant weight loss results, your body may experience a period of adjustment. Manufactured by Alkem Laboratories Ltd, this high-dose pen can trigger gastrointestinal responses as your system adapts to peak GLP-1 levels. Specifically, most users report that these effects are temporary.
1. Common Gastrointestinal Responses
Nausea and Vomiting: The most common side effect.
Bowel Irregularity: Diarrhea or constipation may occur.
Abdominal Bloating: Feeling of fullness due to slowed digestion.
2. Energy and Appetite Shifts
Reduced appetite
Temporary fatigue
Lower calorie intake leading to energy changes
Safety Advice of Hepaglide (Semaglutide) 2.4mg Injection
| Category | Advice |
|---|---|
| Alcohol | Avoid excessive alcohol consumption as it may worsen gastrointestinal side effects. |
| Pregnancy | Contraindicated. Discontinue at least 2 months before planning pregnancy. |
| Breastfeeding | Not recommended due to lack of safety data. |
| Driving | Generally safe, but monitor for dizziness or fatigue. |
| Liver | Use with caution in severe hepatic conditions. |
| Kidney | Maintain hydration and monitor kidney function, especially if vomiting occurs. |
All Substitutes
Obesema(Semaglutide) Injection
Sematrinity(Semaglutide) Injection
Noveltreat(Semaglutide) Injection
Semaglyn(Semaglutide) Injection
Semanext(Semaglutide) Injection
Hepaglide(Semaglutide) Injection
FAQs about Hepaglide (Semaglutide) 2.4mg Injection
1. What is Hepaglide (Semaglutide) 2.4mg Injection used for?
It is used for chronic weight management and obesity treatment in adults.
This is the highest dose in semaglutide therapy.
2. How does Hepaglide 2.4mg work?
It mimics GLP-1 hormone to regulate appetite and blood sugar.
Reduces hunger
Slows digestion
Improves insulin response
3. Is Hepaglide 2.4mg effective for weight loss?
Yes, it delivers maximum weight loss results among semaglutide doses.
4. Who should use Hepaglide 2.4mg?
Patients who have completed lower doses and need maximum results.
5. How should I take Hepaglide 2.4mg?
Inject once weekly.
Use abdomen, thigh, or upper arm.
6. What are common side effects?
Nausea
Vomiting
Diarrhea
7. Is Hepaglide 2.4mg safe?
Yes, when used under medical supervision.
8. Can beginners use Hepaglide 2.4mg?
No, it is only for patients who completed titration.
9. What happens if I miss a dose?
Take within 5 days or skip.
10. Where can I buy Hepaglide 2.4mg?
From verified pharmacies only.
Medically Reviewed: This information is educational and not a substitute for medical advice.
Related Products
500 in stock
Notably, the Wegovy 1mg FlexTouch Pen serves as a critical intermediate dose in the semaglutide weight loss journey. This once-weekly injection provides a higher concentration of the active ingredient to accelerate fat loss and improve appetite suppression. Furthermore, the precision FlexTouch delivery system ensures a simple and accurate application for patients who have completed the initial 0.5mg titration phase.
500 in stock
500 in stock
500 in stock
500 in stock
500 in stock
500 in stock
499 in stock
500 in stock
500 in stock
500 in stock
500 in stock













